Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11903950 BCL-2 inhibitors

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
August 21, 2019
0
Date of Patent
February 20, 2024
0
Patent Application Number
17269003
0
Patent Citations
‌
US Patent 8546399 Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 9006247 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 9029404 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 9034875 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 9045420 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
0
‌
US Patent 9045444 Apoptosis promoters
0
‌
US Patent 9045475 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 9045920 Vehicle door inside handle device
0
‌
US Patent 9072748 BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
0
‌
US Patent 9073855 BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
0
•••
Patent Inventor Names
Yi Chen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11903950
0
Patent Primary Examiner
‌
Susanna Moore
0
CPC Code
‌
G01N 33/743
0
‌
G01N 2021/6439
0
‌
C07J 1/0011
0
‌
C07J 31/003
0
‌
C07J 41/0016
0
‌
C07D 498/14
0
‌
C07D 498/22
0
‌
C07D 513/14
0
‌
C07D 515/14
0
‌
G01N 33/582
0
•••

Find more entities like US Patent 11903950 BCL-2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo